Dendreon seeking takeover offers, Bloomberg says

theflyonthewall.com

Dendreon is working with JPMorgan to solicit takeover offers after sales of its cancer treatment Provenge failed to meet expectations, reports Bloomberg, citing people familiar with the matter.

View Comments (1)